Form4insider filings, from the source

SEC Form 4 · accession 0000899243-15-008453

OCULAR THERAPEUTIX, INC · OCUL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amarpreet Sawhney
Officer — President and CEO · Director · 10% Owner
Period of report
Nov 17, 2015
Accepted (ET)
Nov 18, 2015 · 8:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockNov 17, 2015P10,000$8.25A563,733D
Common StockF1holding———846,377ISee Footnote
Common StockF2holding———471,784ISee Footnote
Common StockF3holding———379,419ISee Footnote
Common StockF4holding———71,969ISee Footnote
Common StockF5holding———189,393ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses